 |
|
Benign Prostatic HyperplasiaIts Natural History, Epidemiologic Characteristics, and Surgical Treatment
Joseph E. Oesterling, MD
Arch Fam Med. 1992;1(2):257-266.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Walsh PC. Human benign prostatic hyperplasia: etiological considerations. Prog Clin Biol Res. 1984;145:1-25.
PUBMED
2. Schröder FH, Blom JHM. Natural history of benign prostatic hyperplasia (BPH). Prostate. 1989;(suppl_2):17-22. 3. Ekman P. BPH epidemiology and risk factors. Prostate. 1989;2(suppl):23-31.
PUBMED
4. Birkhoff JD. Natural history of benign prostatic hypertrophy. In: Hinman F Jr, Boyarsky S, eds. Benign Prostatic Hypertrophy. New York, NY: Springer-Verlag NY Inc; 1983:5-9. 5. Kane MM, Fields DW, Vaughan ED Jr. Medical management of benign prostatic hyperplasia. Urology. 1990;36(suppl):5-12.
PUBMED
6. Graves EJ. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1987. Vital Health Stat. 1989;100:295.
7. Graversen PH, Gasser TC, Wasson JH, Hinman F Jr, Bruskewitz RC. Controversies about indications for transurethral resection of the prostate. J Urol. 1989;141:475-481.
PUBMED
8. Nielsen KT, Christensen MM, Madsen PO, Bruskewitz RC. Symptom analysis and uroflowmetry 7 years after transurethral resection of the prostate. J Urol. 1989;142:1251-1253.
PUBMED
9. Roos NP, Ramsey EW. A population-based study of prostatectomy: outcomes associated with differing surgical approaches. J Urol. 1987;137:1184-1188.
PUBMED
10. Roos NP, Wennberg JE, Malenka DJ, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989;320:1120-1124.
ABSTRACT
11. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate. 1989;(suppl 2):33-50. 12. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy: the Baltimore Longitudinal Study of Aging. Urology. 1991;38(suppl):4-8.
PUBMED
13. Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17:241-260.
PUBMED
14. Franks LM. Benign nodular hyperplasia of the prostate: a review. Ann R Coll Surg Engl. 1954;14:92-106.
PUBMED
15. Ahluwalia MS, Tandon HD. Nodular hyperplasia of the prostate in North India: an autopsy study. J Urol. 1965;93:94-101.
PUBMED
16. Pradhan BK, Chandra K. Morphogenesis of nodular hyperplasia: prostate. J Urol. 1975;113:210-213.
PUBMED
17. Bartsch G, Müller HR, Oberholzer M, Rohr HP. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol. 1979;122:487-491.
PUBMED
18. Bartsch G, Frick J, Rüegg I, et al. Electron microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol. 1979;122:481-486.
PUBMED
19. Lawson RK. The natural history of benign prostatic hyperplasia. AUA Update Ser. 1986;5 (lesson 19):1-8.
20. Moore RA. Benign hypertrophy of the prostate: a morphological study. J Urol. 1943;50:680-710.
21. Swyer GIM. Post-natal growth changes in the human prostate. J Anat. 1944;78:130-145.
PUBMED
22. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474-479.
PUBMED
23. Harbitz TB, Haugen OA. Histology of the prostate in elderly men: a study in an autopsy series. Acta Pathol Microbiol Scand A. 1972;80:756-768.
PUBMED
24. Hølund B. Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol. 1980;14:29-35.
PUBMED
25. Hubly JW, Thompson GJ. Infarction of the prostate and volumetric changes produced by the lesion: report of three cases. J Urol. 1940;43:459-467.
26. Spiro LH, Labay G, Orkin LA. Prostatic infarction: role in acute urinary retention. Urology. 1974;3:345-347.
PUBMED
27. Hinman F Jr. Capsular influence on benign prostatic hyperplasia. Urology. 1986;28:347-350.
PUBMED
28. Watanabe H. Natural history of benign prostatic hypertrophy. Ultrasound Med Biol. 1986;12:567-571.
PUBMED
29. Clarke R. The prostate and the endocrines: a control series. Br J Urol. 1937;9:254-271.
30. Craigen AA, Hickling JB, Saunders CRG, Carpenter RG. Natural history of prostatic obstruction: a prospective survey. J R Coll Gen Pract. 1969;18:226-232.
PUBMED
31. Birkhoff JD, Wiederhorn AR, Hamilton ML, Zinsser HH. Natural history of benign prostatic hypertrophy and acute urinary retention. Urology. 1976;7:48-52.
PUBMED
32. Ball AJ, Feneley RCL, Abrams PH. The natural history of untreated 'prostatism.' Br J Urol. 1981;53:613-616.
PUBMED
33. Barnes RW, Marsh C. Progression of obstruction and symptoms. In: Hinman F Jr, Boyarsky S, eds. Benign Prostatic Hypertrophy. New York, NY: Springer-Verlag NY Inc; 1983:711-713. 34. Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 1990;17:495-507.
PUBMED
35. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol. 1991;145:405-409.
PUBMED
36. Scott WW. What makes the prostate grow. J Urol. 1953;70:477-488.
PUBMED
37. Van der Reis L. Benign prostatic hypertrophy and coronary heart disease: correlation or coincidence? J Am Geriatr Soc. 1959;7:866-869.
PUBMED
38. Rotkin ID. Epidemiology of benign prostatic hypertrophy: review and speculations. In: NIAMDD Workshop Proceedings. Washington, DC: US Government Printing Office; 1975:105-117. 39. Roberts HJ. The role of diabetogenic hyperinsulinism in the pathogenesis of prostatic hyperplasia and malignancy. J Am Geriatr Soc. 1966;14:795-825.
PUBMED
40. Bourke JB, Griffin JP. Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy. Br J Urol. 1966;38:18-23.
PUBMED
41. Lytton B, Emery JM, Harvard BM. The incidence of benign prostatic obstruction. Trans Am Assoc Genitourin Surg. 1967;59:65-71.
42. Armenian HK, Lilienfeld AM, Diamond EL, Bross IDJ. Relation between benign prostatic hyperplasia and cancer of the prostate: a prospective and retrospective study. Lancet. 1974;2:115-117.
PUBMED
43. Greenwald P, Kirmss V, Polan AK, Dick VS. Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst. 1974;53:335-340.
PUBMED
44. Finkle AL. The relationship of sexual habits to benign prostatic hypertrophy. Med Aspects Hum Sex. 1967;1:24-25.
PUBMED
45. Araki H, Watanabe H, Mishina T, Nakao M. High-risk group for benign prostatic hypertrophy. Prostate. 1983;4:253-264.
PUBMED
46. Oishi K, Okada K, Yoshida O, et al. A case-control study of prostatic cancer with reference to dietary habits. Prostate. 1988;12:179-190.
PUBMED
47. Chang HL, Char GY. Benign hypertrophy of prostate. Chin Med J. 1936;50:1707-1722.
48. Conger KB. Racial incidence of prostatism in Hawaii: a report of 172 consecutive cases. J Urol. 1947;58:444-447.
49. Karube K. Study of latent carcinoma of the prostate in the Japanese based on necropsy material. Tohoku J Exp Med. 1961;74:265-285.
PUBMED
50. Tan RE. Prostatic disease in Indonesia. J Urol. 1961;86:428-430.
PUBMED
51. Fay R. Prostatic obstruction in Chinese populations. In: Hinman F Jr, Boyarsky S, eds. Benign Prostatic Hypertrophy. New York, NY: Springer-Verlag NY Inc; 1983:27-29. 52. Incidence of prostatic enlargement among 6975 males. Proc Life Extension Examiners. 1940;2:92-94.
53. Randall A. Surgical Pathology of Prostatic Obstructions. Baltimore, Md: Williams & Wilkins; 1931. 54. Husain I, Kazim EM. Urological evaluation of the tropical patient. In: Husain I, ed. Tropical Urology and Renal Disease. New York, NY: Churchill Livingstone Inc; 1984:11-46. 55. Holtgrewe HL, Mebust WK, Dowd JB, Cockett ATK, Peters PC, Proctor C. Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol. 1989;141:248-253.
PUBMED
56. Gofin R. The health status of elderly men: a community study. Public Health. 1982;96:345-354.
PUBMED
57. D'Aunoy R, Schenken JR, Burns EL. The relative incidence of hyperplasia of the prostate in the white and colored races in Louisiana: an analysis of 325 glands removed at operation. South Med J. 1939;32:47-52.
58. Derbes V deP, Leche SM, Hooker CW. The incidence of benign prostatic hypertrophy among the whites and Negroes in New Orleans. J Urol. 1937;38:383-388.
59. Lytton B, Emery JM, Harvard BM. The incidence of benign prostatic obstruction. J Urol. 1968;99:639-645.
PUBMED
60. Sidney S, Quesenberry C Jr, Sadler MC, Lydick ED, Guess HA, Cattolica EV. Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology. 1991;38(suppl):13-19.
PUBMED
61. Rotkin ID. Origins, distribution, and risk of benign prostatic hypertrophy. In: Hinman F Jr, Boyarsky S, eds. Benign Prostatic Hypertrophy. New York, NY: Springer-Verlag NY Inc; 1983:10-21. 62. Fowler FJ Jr, Wennberg JE, Timothy RP, Barry MJ, Mulley AG Jr, Hanley D. Symptom status and quality of life following prostatectomy. JAMA. 1988;259:3018-3022.
FREE FULL TEXT
63. Barry MJ. Medical outcomes research and benign prostatic hyperplasia. Prostate. 1990;(suppl 3):61-74. 64. Barry MJ, Mulley AG Jr, Fowler FJ, Wennberg JW. Watchful waiting vs immediate transurethral resection for symptomatic prostatism: the importance of patients' preferences. JAMA. 1988;259:3010-3017.
FREE FULL TEXT
65. Epstein RS, Lydick EG, deLabry L, Vokonas PS. Age-related differences in risk factors for prostatectomy for benign prostatic hyperplasia: the VA Normative Aging Study. Urology. 1991;38 (suppl):9-12.
PUBMED
66. Mebust WK, Holtgrewe HL. Current status of transurethral prostatectomy: a review of the AUA National Cooperative Study. World J Urol. 1989;6:194-197.
67. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate. 1990;16:39-48.
PUBMED
68. Janknegt RA. Surgical management for benign prostatic hyperplasia: indications, techniques, and results. Prostate. 1989;(suppl 2):79-93. 69. Chilton CP, Morgan RJ, England HR, Paris AMI, Blandy JP. A critical evaluation of the results of transurethral resection of the prostate. Br J Urol. 1978;50:542-546.
PUBMED
70. Neal DE, Ramsden PD, Sharples L, et al. Outcome of elective prostatectomy. BMJ. 1989;299:762-767.
FREE FULL TEXT
71. Wennberg JE, Roos N, Sola L, Schori A, Jaffe R. Use of claims data systems to evaluate health care outcomes: mortality and reoperation following prostatectomy. JAMA. 1987;257:933-936.
FREE FULL TEXT
72. Stephenson WP, Chute CG, Guess HA, Schwartz S, Lieber M. Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester, Minnesota: 1980-1987; a population-based study. Urology. 1991;38(suppl): 32-42.
PUBMED
73. Andersen TF, Brønnum-Hansen H, Sejr T, Roepstorff C. Elevated mortality following transurethral resection of the prostate for benign hypertrophy! but why? Med Care. 1990;28:870-879.
PUBMED
74. Singh M, Tresidder GC, Blandy JP. The evaluation of transurethral resection for benign enlargement of the prostate. Br J Urol. 1973;45:93-102.
PUBMED
75. Holtgrewe HL, Valk WL. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2015 cases. J Urol. 1962;87:450-459.
PUBMED
76. Melchior J, Valk WL, Foret JD, Mebust WK. Transurethral prostatectomy: computerized analysis of 2223 consecutive cases. J Urol. 1974;112:634-642.
PUBMED
77. Isaacs JT. Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention. Prostate. 1990;(suppl 3):1-7. 78. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, Writing Committee. Transurethral prostatectomy: immediate and postoperative complications—a cooperative study of 13 participating institutions evaluating 3885 patients. J Urol. 1989;141:243-247.
PUBMED
79. Lubitz J, Riley G, Newton M. Outcomes of surgery among the Medicare aged: mortality after surgery. Health Care Financ Rev. 1985;6:103.
PUBMED
80. Meyhoff HH, Nordling J. Long-term results of transurethal and transvesical prostatectomy: a randomized study. Scand J Urol Nephrol. 1986;20:27-33.
PUBMED
81. Kolmert T, Norlén H. Transurethral resection of the prostate: a review of 1111 cases. Int Urol Nephrol. 1989;21:47-55.
PUBMED
82. Lund B-L, Dingsør E. Benign obstructive prostatic enlargement: a comparison between the results of treatment by transurethral electroresection and the results of open surgery. Scand J Urol Nephrol. 1976;10:33-38.
PUBMED
83. Gupta NP, Mohanty NK, Reddy PS, Wadhwa SN, Singh SM. A high risk factor score in the management of benign prostatic hyperplasia. Br J Urol. 1986;58:296-298.
PUBMED
84. Møller-Nielsen C, Lundhus E, Møller-Madsen B, et al. Sexual life following 'minimal' and 'total' transurethral prostatic resection. Urol Int. 1985;40:3-4.
PUBMED
85. Hargreave TB, Stephenson TP. Potency and prostatectomy. Br J Urol. 1977;49:683-688.
PUBMED
86. Malone PR, Cook A, Edmonson R, Gill MW, Shearer RJ. Prostatectomy: patients' perception and long-term follow-up. Br J Urol. 1988;61:234-238.
PUBMED
87. Holtgrewe HL, Valk WL. Late results of transurethral prostatectomy. J Urol. 1964;92:51-55.
PUBMED
88. Jensen KM-E, Jørgensen JB, Mogensen P. Urodynamics in prostatism, I: prognostic value of uroflowmetry. Scand J Urol Nephrol. 1988;22:109-117.
PUBMED
89. Lepor H, Rigaud G. The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism. J Urol. 1990;143:533-537.
PUBMED
90. Bruskewitz RC, Larsen EH, Madsen PO, Dørflinger T. 3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol. 1986;136:613-615.
PUBMED
91. Ball AJ, Smith PJB. The long-term effects of prostatectomy: a uroflowmetric analysis. J Urol. 1982;128:538-539.
PUBMED
92. Meyhoff HH, Nordling J, Hald T. Economy in transurethral prostatectomy. Scand J Urol Nephrol. 1985;19:17-20.
PUBMED
|
